HOMA-IR is a simple way to estimate how resistant your body is to insulin, calculated from just two fasting blood values. Many women with PCOS first meet the term in a private lab report or a support group, then wonder whether their number is “bad”. This article explains how to calculate it correctly, the ranges commonly cited, and, just as importantly, the limits of the test so you neither panic nor over-trust a single number.

Before the maths, one thing should be clear: HOMA-IR is an estimation tool, not an official diagnostic test. It is useful for a rough picture and for tracking change over time, but your PCOS treatment decisions should not rest on this number alone. To understand how insulin connects to PCOS overall, start with our insulin resistance guide.

What HOMA-IR is and what it measures

HOMA stands for Homeostatic Model Assessment, a model built to estimate insulin function from the fasting state. The “IR” version gives you an estimate of insulin resistance, the condition where muscle, liver and fat cells respond less to insulin, so the pancreas has to release more insulin to keep blood sugar normal.

Insulin resistance is one of the main drivers of PCOS for many women. It contributes to higher testosterone, irregular periods, and difficulty losing weight. That is why many lab reports now print HOMA-IR alongside fasting insulin. If you want the meaning of the fasting insulin value on its own, read our article on fasting insulin and PCOS.

The actual formula and a step-by-step calculation

HOMA-IR needs only two values, both drawn after an 8 to 12 hour fast (plain water is allowed):

  • Fasting insulin, usually in µIU/mL (mIU/L, the same value).
  • Fasting glucose, in mmol/L in Malaysia, or mg/dL in some reports.

If your glucose is in mmol/L (standard in Malaysia):

HOMA-IR = (fasting insulin × fasting glucose) ÷ 22.5

If your glucose is in mg/dL:

HOMA-IR = (fasting insulin × fasting glucose) ÷ 405

The 22.5 and 405 are simply constants that adjust for the different glucose units, so make sure you use the right divisor for the unit on your report.

A worked example: say your fasting insulin is 12 µIU/mL and fasting glucose is 5.4 mmol/L. Then HOMA-IR = (12 × 5.4) ÷ 22.5 = 64.8 ÷ 22.5 = 2.88. You do not need to do this by hand; most labs already print the value, and many free online calculators can check it. What matters is that you understand what goes into the formula, so you can spot if a value is missing or in the wrong unit.

How to interpret your number

Here is where care is needed, because there is no single cut-off agreed worldwide. The following ranges are a rough guide commonly cited in studies, not hard lines:

  • Below 1.0: good insulin sensitivity.
  • 1.0 to 1.9: a range usually considered normal.
  • 2.0 and above: starts to suggest insulin resistance in many populations.
  • 2.5 to 2.9 and above: more strongly suggests meaningful insulin resistance.

Ethnic context matters. Most “universal” cut-offs come from European or North American populations. Studies in Asian women, including Thai women with PCOS, suggest lower cut-offs, around 1.7 to 2.0, because insulin resistance can be present at lower values than in Western groups. That means a 2.2 that looks “moderate” on a Western chart can be more meaningful for a Malaysian woman. This is exactly why a doctor interprets HOMA-IR alongside your full picture, not in isolation.

Why a single HOMA-IR number cannot be trusted blindly

HOMA-IR has real, honest weaknesses you should know:

  • Insulin assays are not standardised between labs. Different insulin kits give different readings, so HOMA-IR from Lab A is not directly comparable to Lab B. If you want to track change, repeat the test at the same lab.
  • High variability in one individual. A single reading can vary, with a coefficient of variation reported as high as 30 percent. One high number on one day may not persist.
  • Not a validated diagnostic test for routine clinical use. Research cut-offs are not approved as a standalone diagnostic. HOMA-IR is better at placing you in a broad “sensitive” or “resistant” category than at giving a precise measurement.

For these reasons, the international PCOS guideline (Monash, ESHRE and ASRM 2023, consistent with the Endocrine Society position) does not recommend HOMA-IR for routine blood sugar screening. Instead, the oral glucose tolerance test (OGTT) and HbA1c are more reliable ways to assess metabolic risk. Read our guide on OGTT for PCOS to understand the test clinics prioritise.

Malaysian context: where to get this test

In government clinics, fasting insulin is usually not a routine test. KKM Klinik Kesihatan (RM1 for citizens, specialist follow-up about RM5) typically screens blood sugar using fasting glucose, HbA1c or OGTT, the tests the guideline actually recommends. To get fasting insulin and HOMA-IR, most women need a private lab or clinic, and the cost varies between providers, so check current pricing with your chosen lab.

So do you need this test? For most women with PCOS, OGTT and HbA1c are already enough to assess metabolic risk, and both are available at government clinics at low cost. HOMA-IR can be useful extra information, but it is not a requirement. If you are newly diagnosed and unsure which tests to do first, our newly diagnosed guide lays out the early steps clearly.

What to do with your result

Whether your HOMA-IR is 1.5 or 3.0, the core actions are much the same: talk to a gynaecologist or endocrinologist, bring your full report, and focus on what genuinely helps insulin resistance, namely daily movement, enough sleep, low glycaemic index food, and modest weight loss if relevant. Some women also consider supplements like inositol after discussing with their doctor; see our supplements page for an honest view of the evidence, including the doses used in studies.

When should you see a doctor urgently? If you have diabetes symptoms such as frequent thirst, frequent urination, or unexpected weight loss, do not wait for a HOMA-IR result; get a proper blood sugar assessment straight away. Remember too that PCOS raises the long-term risk of type 2 diabetes and heart disease, so periodic metabolic monitoring is worthwhile even when today’s number looks fine.